STOCKWATCH
·
Pharmaceuticals
New Launch17 Jun 2025, 11:30 am

Veerhealth Care's Ayuveer Products Now Available on Myntra

AI Summary

Veerhealth Care Limited is pleased to announce that its brand Ayuveer, specializing in ayurvedic medicines and oral care products, is now available on Myntra. This step will significantly enhance the brand's visibility and market opportunities. The company expects a substantial addition to its revenue in the current financial year, with total revenues of ~ 35-40 crores and PAT of 10% in F.Y. 2025-26. The company has also successfully cleared the USFDA inspection, allowing it to export drug (OTC) products to the USA markets and other potential markets.

Key Highlights

  • Ayuveer products now available on Myntra
  • Expected substantial addition to revenue in the current financial year
  • Total revenues of ~ 35-40 crores and PAT of 10% in F.Y. 2025-26
  • Successfully cleared USFDA inspection
  • Opportunity to export drug (OTC) products to the USA markets and other potential markets
VEERHEALTH
Pharmaceuticals
Veerhealth Care Limited

Price Impact